Loading

Journal of Human Nutrition and Food Science

Impact of Diet on Physical and Mental Health Consequences of Covid-19 Patients in Bangladesh

Research Article | Open Access Issue 2333-6706
Article DOI :

  • 1. Department of Nutrition and Food Technology, University of Science and Technology, Bangladesh
+ Show More - Show Less
Corresponding Authors
Shireen Nigar, Department of Nutrition and Food Technology, Jashore University of Science and Technology, Jashore, Bangladesh, 7408, Cell: +8801873029043
INTRODUCTION

In December 2019, an unprecedented wave of pneumonia of unspecified etiology unfolded in Wuhan City, Hubei province in China. A novel coronavirus was recognized as the contributing agent and was subsequently labeled COVID-19 by the World Health Organization [1]. COVID-19 is an acute inflammatory process, so critically affected patients have to fight the blow of the emerging inflammatory storm that includes fever, decreased appetite, and weight loss as an inevitable trend [2]. Fatigue, cough, dyspnea, chest pain, altered smell and taste, and cognitive impairment are among the first documented chronic symptoms [3-5]. A research of 43,565 persons conducted in November 2020 discovered that hair loss, often known as alopecia, is connected to severe COVID-19 illness [6]. Only 13% of patients in Italy were utterly rid of COVID-19 symptoms after 60 days, with 55% having at least three persisting symptoms and 32% having one or two [7].These findings raise serious concerns about COVID-19’s long-term health consequences.

A combined data incorporating 227,219 confirmed cases and 14,364 deaths show that the male-to-female case fatality ratio is frequently uplifted through all age groups and may even be most evident in middle age [8]. Covid-19 has wreaked havoc on urban areas, primarily megacities. Population density and socializing are considered key attributes of the success of cities [9]. NCD (non-communicable disease) prevention and management are critical during this pandemic since NCDs are a crucial threat to COVID- 19 patients. In Spain, China, and the United States, researchers found a link between COVID-19 severity and NCDs [10]. Tobacco smoke exposure is a risk factor for lung disease [11], and cigarette smoking is a notable risk factor for viral and bacterial infections [12]. The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) had the same clinical symptoms as COVID-19 and showed a link between smoking status and mortality rate [13].

Infectious diseases have plagued humanity for centuries [14], eliciting various psychological responses and altering entire populations’ behavior patterns. Research shows that isolation and many other enforced limits exacerbate psychological suffering, including depression and anxiety symptoms [15]. Female sex, urban living, low or no physical activity, sleep disturbance, self-reported moderate/poor health status, smoking, existing COVID-19 symptoms, and fear of COVID-19 re-infection have all been linked to depression in previous studies [16-20]. COVID19’s prognosis might be worsened by depression [21]. Patients with depression may have a negative attitude toward antiviral therapy, which could make it challenging for them to adhere to their treatment and recover [22]. COVID-19 has been linked to being associated with neurological impairment in recent studies [23]. Depression and other psychiatric illnesses can affect cognitive functioning and occupational performance [24, 25]. During the COVID-19 pandemic in Bangladesh, depression was observed in a variety of populations, including the general public (47.2%) [26], university students (62.9%) [27], medical students (49.9%) [28], and healthcare workers (39.5%) [29]. According to a recent study in Bangladesh, 56.6 percent of 153 COVID- 19 patients reported depression [30].

When an illness is novel and causes severe symptoms or mortality, fear, anxiety, and a lack of understanding of the disease can lead to stereotyping, discrimination, and labeling of people who have it. The stigmatized group may be subjected to discriminatory behaviors such as isolation, refusal to give service, harassment, and bullying. Such behaviors may jeopardize disease-prevention initiatives, leading to a lack of testing and healthy practices such as wearing masks to avoid discrimination [31].

Several medicines have been tried to treat life-threatening COVID-19 infection, but the perfect combination has yet to be discovered. Nutrition and food should be supplied for these patients without scientific proof to control the pandemic [32]. Dietary management should be considered as a measure of strengthening immunity and utilizing the antiviral properties of a few nutrients [33]. Citrus fruit is one of nature’s best and most accessible sources of vitamin C, a crucial ingredient for immune system support [34]. Even though practically all fruits benefit human health and immunity, it has been proven that apples, sitaphal, and papaya have antiviral properties against particular viruses [35,36].

Fresh vegetables containing suitable amounts of zinc, iron, and vitamins A, B 12, B6, C, and E are vital for maintaining good health [37]. Adding high biological value proteins (such as those found in eggs, lean meat, fish, and dairy) that contain all essential amino acids may have anti-inflammatory properties. Furthermore, several amino acids, such as arginine and glutamine, are well known for their immune system-modulating properties [38]. On the other hand, polar lipids, such as phospholipids, glycolipids, or sphingolipids (also present in food sources of Omega-3 fatty acids, such as fish and fish oils) can inhibit platelet-activating factor (PAF) and its receptor, resulting in anti-inflammatory actions that may be useful in COVID-19 [39]. Studies have linked a healthy diet and physical activity to improved mental health [17, 40]. These dietary changes may increase the immune system, impacting the host’s infection response [18]. In March 2020, the virus was discovered to have spread to Bangladesh. The first three coronavirus cases were reported on March 8. [41].

After India, Bangladesh is the second-most afflicted country in South Asia [42]. Bangladesh confronts considerable challenges in combatting COVID-19 due to its dense population and the housing of millions of stateless Rohingya refugees in sprawling refugee camps that facilitate the spread of diseases [43,44]. The COVID-19 epidemic severely impacts family and individual wages in Bangladesh, with roughly 13% of individuals losing their jobs; lower and middle-income classes have seen significant income drops in recent months. Meanwhile, the Bangladesh Institute of Development Studies (BIDS) claims that national poverty will rise by 25.13 percent [45].

The coronavirus COVID-19 pandemic is the most severe worldwide health epidemic since World War II. This extensive study aimed to discover the persistent symptoms, mental health outcomes, and social consequences after 90 days of being tested positive in patients with covid-19. As well as assess the influence of disease days’ diet on persistent Symptoms and mental health outcomes (Tables 1-3).

Table 1: Demographic and Clinical Characteristics and Social Factor Status.

Variable

Categories

Mean ± SD

N, (%)

Gender

Male

 

139, (69.50)

Female

 

61, (30.50)

 

 

Residence

Urban

 

102, (51.0)

Nearest Urban

 

50, (25.0)

Village

 

48, (24.0)

Occupation

Job

 

122, (61.0)

Business

 

25, (12.5)

 

 

Educational status

higher

education

 

115, (57.50)

SSC and HSC

 

70, (35.0)

<SSC

 

13, (6.5)

Age of the subjects (years)

 

38.36±10.19

 

Monthly income in taka (n=41)

 

31463 ±19477

 

Number of family members

 

4.7±2.3

 

Family members affected

 

1.7±1.13

 

High viral load

 

 

29, (14.5)

Frequency of being positive

One time

 

155, (77.5)

>One time

 

45, (22.5)

 

 

The period of sickness

≤15 days

 

88, (44.0)

16-30 days

 

78, (39.0)

>30 days

 

34, (17.0)

Treatment taking place

home

 

169, (84.50)

Hospital

 

31, (15.50)

Smoking

 

 

35, (17.5)

Fear of recontamination

 

 

42, (21.0)

Financially Affected

 

 

116, (58.0)

Physical Exercise

 

 

83, (41.5)

Patients with Non-Communicable Diseases

Diabetes

 

 

33, (16.5)

Hypertension

 

 

33, (16.5)

Cardiovascular disease

 

 

11, (5.5)

Asthma

 

 

12, (6.0)

Kidney

 

 

4, (2.0)

Other

 

 

47, (23.5)

 

Social Factor Status

Severely discriminated

Moderately discriminated

No discrimination

37, (18.5%)

15, (7.50%)

148, (74.0%)

 

Table 2: Prevalence of Persistent Symptoms and Mental Health Outcomes.

Variables

N (%)

Male, N (%)

Female, N (%)

Fatigue

69.50%

94, (67.6)

45, (73.8)

Dyspnea

40.50%

49, (35.3)

32, (52.5)

Alopecia

35.50%

38, (27.3)

33, (54.1)

Headache

30.0%

29, (20.9)

31, (50.8)

Dry or wet cough

29.0%

40, (28.8)

18, (29.5)

Sore throat

23.50%

27, (19.4)

20, (32.8)

Chest pain

21.50%

31, (22.3)

12, (19.7)

Sweating

7.50%

9, (6.5)

6, (9.8)

Loss of the sense of taste & smell

3.0%

4, (2.9)

2, (3.3)

Difficulty completing the daily activity

13.50%

13, (9.4)

14, (23.0)

Having difficulty in professional life

30.0%

34, (24.5)

26, (42.6)

Other Complication

17.50%

26, (18.7)

9, (14.8)

Mental Health Outcomes

Depression

71, (35.5)

45, (32.4)

26, (42.6)

Sleeping disturbance

73, (36.50)

41, (29.5)

32, (52.5)

Poor appetite or Over-eating

35, (17.50)

21, (15.1)

14, (23.0)

Memory impairment

97, (48.50)

59, (42.4)

38, (62.3)

Trouble Concentrating on things

69, (34.5)

48, (34.5)

21, (34.4)

 

Table 3: Patient’s Food Intake during Covid-19 Affected Days and Prevalence of Persistent Symptoms according to Different Food Intake.

Variables

Regular, N (%)

Irregular, N (%)

Never, N (%)

Χ2/P-Value

Citrus fruits Intake

196, (98.0)

4, (2.0)

-

-

Other fruits Intake

137, (68.5)

50, (25.0)

13, (6.5)

-

Vegetable Intake

175, (87.5)

21, (10.5)

4, (2.0)

-

Fish Intake

142, (71.0)

37, (18.5)

21, (10.5)

-

Meat Intake

107, (53.5)

79, (39.5)

14, (7.0)

-

Milk Intake

105, (52.5)

29, (14.5)

66, (33.0)

-

Egg Intake

153, (76.5)

35, (17.5)

12, (6.0)

-

Vegetable Intake

Chest distress

32, (18.3)

8, (38.1)

3, (75.0)

11.281 /0.004

Cough

50, (28.6)

5, (23.8)

3, (75.0)

4.401 /0.111

Dyspnea

66, (37.7)

11, (52.4)

4, (100.0)

7.670 /0.022

Other symptoms

suffering now

 

27, (15.4)

 

5, (23.8)

 

3, (75.0)

 

10.259 /0.006

Having difficulty in

professional life

 

47, (26.9)

 

11, (52.4)

 

2, (50.0)

 

6.594/0.037

Other Fruits Intake

Depression

42, (30.7)

21, (42.0)

8, (61.5)

6.175 /0.046

Fatigue

97, (70.8)

29, (58.0)

13, (100.0)

8.934 /0.011

Dry/Wet cough

35, (25.5)

15, (30.0)

8, (61.5)

7.502 /0.023

Did not suffer from

any

symptoms

 

23, (62.2)

 

14, (37.8)

 

0, (0.0)

 

6.210 /0.045

Did not return to

regular

activity

 

12, (8.8)

 

12, (24.0)

 

3, (23.1)

 

8.378/0.015

Egg Intake

Sleeping

disturbance

56, (36.6)

9, (25.7)

8, (66.7)

6.468/0.039

Milk Intake

Chest distress

16, (15.2)

6, (20.7)

21, (31.8)

6.614 /0.037

SUBJECTS AND METHODOLOGY

Study design and Participants

This research was conducted by the Jashore University of Science and Technology’s (JUST) Department of Nutrition and Food Technology. The research ethics committee of the university approved the study protocol. The JUST Genome Center provided the patients’ basic information and contact information. The research is a cross-sectional survey between December 2, 2020, and January 12, 2021. For this study, a total of 411 patients were contacted. Among them, 203 patients verbally agreed to participate in the trial. Three samples were eliminated during the screening process due to missing data. The participants in this study ranged in age from 20 to 60 years old and had tested positive for COVID-19 at the JUST Genome Center. The participants tested positive between August 20, 2020, to October 13, 2020. They tested positive by using real-time PCR machines. COVID-19 patients in Bangladesh were required to be quarantined for 14 days or more after testing positive and later tested negative, according to treatment standards. Thus, it was ensured that the time since testing positive for the covid-19 for all subjects was more than three months. The patients are from Jashore, Shatkhira, Jhenaidah, and Chuadanga. The data were collected from December 2, 2020, to January 12, 2021.

Questionnaire development

The data was collected from the respondents using a closedended questionnaire. A pre-tested, semi- structured English questionnaire (translated into Bangla during the interview) was used to collect information from the participant. The questionnaire was pre-tested on ten people in a group similar to the target population to check that the material was appropriate and understandable and that the questions flowed well. The questionnaire had seven parts:

  1. Patient demographics: age, gender, religion, monthly income, living area, profession, degree of education, present condition, recovery timeframes, number of family members, and number of family members infected.
  2. Patient’s cigarette smoking/tobacco use, difficulty with daily tasks, return to work, financial impact/loss, maintaining physical exercise at least three times per week, memory impairment, and patient fear about recontamination.
  3. Patient’s chronic disease status: Diabetes mellitus, Hypertension, Cardiovascular disease, Asthma, Kidney disease, and others.
  4. Persistent symptoms: Fatigue, Chest pain, Cough, Dyspnea, Sweating, Sore throat, Alopecia, Anosmia/Ageusia, Headache, and Others.
  5. Mental health outcomes: A validated Bangla version of the PHQ-9 [46] was used to determine the severity of depressive symptoms [47, 48]. The PHQ-9 is a nine-item questionnaire that asks about sleep, tiredness, changes in appetite, concentration problems, and suicidal thoughts in the last two weeks. “Do you have difficulties falling or staying asleep, or do you sleep too much?” [49] Is an example question with a four-point Likert scale ranging from 0 (“Not at all”) to 3 (“Nearly every day”). The total score was determined by adding the raw scores of each item, which ranged from 0 to 27, with a higher score indicating greater depression severity. The reliability coefficient Cronbach’s α of the PHQ-9 scale was 0.83 for this study.
  6. Social factor: For the current study with COVID-19 patients, we used a 5-item perceived discrimination scale based on comparable scales previously used to assess HIV patients’ discrimination. “My family refuses to live with me,” “I am rejected by my neighbors and community,” “my family members are rejected by relatives and neighbors,” “relatives and friends are terrified of me,” and “I am
    subjected to verbal abuse” are the inquiries. “None of the time” (score 0), “a little” (score 1), “moderate” (score 2), “severe” (score 3), and “extremely serious” (scoring 4) were among the items replies (score 4). A higher score suggests more discrimination is being experienced [50].
  7. Patient’s dietary pattern during disease days: Taking citrus fruit, other fruits, Vegetables, Fish, Meat, Milk, and Egg (Regularly, Irregularly, Never) when they were positive for covid-19 were recorded. Taking a specific food group at least once a day was considered regular, whereas at least three times a week was considered irregular.

Data collection and analysis

“Data” was collected over the phone in the presence of a qualified supervisor. The “JUST” Genome Center’s electronic medical record system provided demographic information such as age, gender, and religion. The data was entered and analyzed using Statistical Package for Social Sciences (SPSS v16 for Windows). Descriptive statistics (e.g., frequencies, percentages, means, and standard deviations) and some first-order analyses (e.g., Chi-square tests and independent t-tests) were performed. A P-value of <0.05 was considered significant in all the analyses.

RESULTS

One hundred thirty-nine men (69.50 %) and 61 women (30.50 %) were among the participants. The majority of the subject’s residents are Urban (51 %). In terms of occupation, the majority of the participants were job holders (61 %). The participant responded about their educational background, which could affect their understanding of Covid-19 and health awareness. A total of 115 people (57.50%) have completed higher education. Around 35 % of participants have SSC and HSC degrees, while 13 (6.5%) participants do not have an SSC degree. The Mean ±SD age was 38.36±10.18 years old. The Mean ±SD monthly income was 31463 ±19477 taka (n= 41). Besides this, the mean ±SD Number of family members was 4.7±2.3, and 1.7±1.13 (Mean ±SD) numbers of family members affected by Covid-19. Concerning the non-communicable disease history, a large number of participants have diabetes (33), cardiovascular disease (11), hypertension (33), and other (46) chronic diseases. Around 78% of the participants tested positive for covid-19 once, while 22.50% tested positive more than once. Moreover, 14.50% of patients had a high viral load during their real-time PCR tests. In addition, 17% of participants were covid-19 positive for more than 30 days. Only 15.50 % of the patient admitted to the hospital. There were no female patients who smoked. Only 25 % of the male participants smoke cigarettes or use other tobacco products. Approximately 41.5 % of individuals exercise at least three times per week. Because of the covid-19 pandemic, 58% of participants claimed they had been financially affected. On top of that, 18.50% had experienced horrible treatment in their community for being affected by Covid-19.

The common persistent symptoms among the participants are fatigue (69.50%), dyspnea (40.50%), alopecia (35.5%), headache (30.0%), cough (30.0%), and Chest pain (21.50%). Among the female Samples, those suffering from fatigue (73.8%), dyspnea (52.5%), alopecia (54.1%), and headache (50.8%) are significantly high, while fatigue (67.6%) and dyspnea (35.3%) are more common among the male patients. Female individuals get twice as many headaches and alopecia as male participants. Compared to male participants (9.4 %), the percentage of female participants (23.0%) who have difficulty completing daily activities is more than double. Furthermore, female participants (42.6%) face more professional challenges than male participants (24.5%). According to the findings, 71 patients (35.5%) had moderate or severe depression. While 48.50 % of the patients have memory impairment, 34.50% have difficulty concentrating. Furthermore, 17.50% of people have eating disorders, and 36.50% have sleep disturbances. Female participants (42.6%) are more depressed than male participants (32.4%). Sleep disturbances and eating disorders are also more common among women than men.

In this study, participants were questioned about their diets while infected with covid-19. The majority of participants (98%) took citrus fruits regularly. Regular intake of Other fruits with citrus fruits was typical among the participants (68.50%). Besides, 87.50% of participants took vegetables regularly. Among the protein-rich food, egg intake (76.50%) was higher. Respectively, 71%, 53.50%, and 52.50% of patients regularly took fish, meat, and milk. However, some participants never consumed milk (33%), fish (10.5%), and meat (7%) when they were affected by Covid-19.

In addition, 61.5% of patients with depression never ate other fruits. Participants who did not take Other fruits regularly are suffering from fatigue (100%), cough (61.5%), and also having difficulty completing their daily tasks (23.1%). Participants who abstained from Other fruits were significantly more likely to report fatigue (P=0.011), cough ((P=0.023), and difficulty completing the daily task (P=0.015). Participants who had vegetables regularly; most of them are free from cough (71.4%), dyspnea (62.3%), chest distress (81.7%), and other symptoms (15.45%). Besides, 73.1% did not have difficulty in their professional life. Regular vegetable consumers were significantly less likely to report dyspnea ((P=0.022), chest distress (P=0.004), other symptoms (P=0.006), and difficulty in professional life (P=0.022). Sleeping disruption (66.7%) and chest distress (48.8 %) were frequent among those who had never had eggs or milk. Regular egg and milk consumers were significantly less likely to report sleeping disturbance (P=0.039) and chest distress (P=0.037).

DISCUSSION

Among the 200 participants, 15.50 % of the participants were hospitalized. This finding is close to a recent study in which 21% were reported being hospitalized with COVID-19 [51]. Twenty-five percent of the male participants smoke cigarettes or use other tobacco products. Tobacco smoke exposure is a risk factor for lung disease [11], and cigarette smoking is a notable risk factor for viral and bacterial infections [12]. Because of the covid-19 pandemic, 58% of participants claimed they had been financially affected. This figure is lower than Vietnam’s (66.9%) but higher than India’s (45.6%) [52, 53]. On top of that, 18.50% of the participants were severely abused by their community because of being positive for Covid-19. Such behaviors may jeopardize disease-prevention initiatives, leading to a lack of testing and healthy practices such as wearing masks to avoid discrimination [31].

According to this study, the common persistent symptoms among the participants are fatigue (69.50%), dyspnea (40.50%), alopecia (35.5%), headache (30.0%), cough (30.0%), and Chest pain (21.50%). Fatigue, cough, dyspnea, chest pain, altered smell and taste, and cognitive impairment are among the first documented chronic symptoms [3, 4, 5]. A research of 43,565 persons conducted in November 2020 discovered that hair loss, often known as alopecia, is connected to severe COVID-19 illness [6]. According to a recent study, the post-COVID-19 syndrome is characterized by several symptoms, the most common of which are fatigue and sleep disturbances [54]. Some prevalent symptoms are dyspnea, joint pains, anxiety, low mood, cognitive dysfunction, chest pain, thromboembolism, hair loss, and chronic kidney disease [54].

COVID-19 has been linked to being associated with neurological impairment in recent studies [23]. While 48.50 % of the patients have memory impairment, 34.50% have difficulty concentrating. Furthermore, 17.50% of people have eating disorders, and 36.50% have sleep disturbances. Another recent study found that 37.3 % of people had memory problems, 35.1 % had sleep disturbance, and 25.4

% had trouble concentrating [55]. The COVID-19 pandemic has resulted in poor sleep quality and insomnia, according to studies in the general population and COVID-19 patients [56, 57]. Our findings showed that 71 patients (35.5%) had moderate or severe depression. A study in Bangladesh conducted in a similar setting with a similar age range, education level, and resident areas finds that 47.2% of participants had depression four months after the COVID-19 outbreak. Among the female participants, those suffering from fatigue (73.8%), dyspnea (52.5%), alopecia (54.1%), and headache (50.8%) are higher, while Fatigue (67.6%) and Dyspnea (35.3%) are more common among the male patients. Female participants are twice likely to suffer from headaches and alopecia than male participants. Difficulty completing daily activities and facing professional challenges is also double among the female participants. More female participants (42.6%) have depression than male participants (32.4%). Previous research has found that females are more likely than males to be depressed [58, 59]. Sleep disturbances and eating disorders are also more common among women than men. Females may be more emotionally vulnerable and more susceptible to pressures associated with negative psychological impacts, such as the death of friends or family members. These aspects may be relevant during a pandemic [59, 60].

At the start of the COVID-19 pandemic, the focus was on controlling the virus’s transmission and preventing infection. The health of COVID-19 survivors should be a priority now. [61]. Nutrition and food should be supplied for these patients without scientific proof to control the pandemic [32]. In this study, participants were questioned about their diets while infected with covid-19. The majority of participants (98%) took citrus fruits regularly. Citrus fruit is one of nature’s best and most accessible sources of vitamin C, a crucial ingredient for immune system support [34]. The participants regularly consumed other fruits with citrus fruits every day (68.50%). Even though practically all fruits benefit human health and immunity, it has been proven that apples, sitaphal, and papaya have antiviral properties against particular viruses [35,36].

Besides this, 87.50% of participants took vegetables regularly. Fresh vegetables containing suitable amounts of zinc, iron, and vitamins A, B 12, B6, C, and E are vital for maintaining good health [37]. Among the protein-rich food, egg intake (76.50%) was higher. Respectively, 71%, 53.50%, and 52.50% of patients regularly took fish, meat, and milk. However, some participants never consumed milk (33%), fish (10.5%), and meat (7%) when they were affected by Covid-19. It has been suggested that adding high biological value proteins (such as those found in eggs, lean meat, fish, and dairy) that contain all of the essential amino acids may have anti-inflammatory properties [38].

In addition, 61.5% of patients with depression never ate other fruits. Epidemiological studies have reported a lower risk of depression linked to high fruit and vegetable consumption [62]. Participants who did not take other fruits regularly are suffering from fatigue (100%), Cough (61.5%), and also having difficulty completing their daily tasks (23.1%). Participants who abstained from Other fruits were significantly more likely to report Fatigue (P=0.011), Cough ((P=0.023), and Difficulty completing the daily task (P=0.015). Participants who had vegetables regularly; most of them are free from cough (71.4%), dyspnea (62.3%), Chest distress (81.7%), and other symptoms (15.45%). Besides, 73.1% did not have difficulty in their professional life. Regular vegetable consumers were significantly less likely to report dyspnea ((P=0.022), Chest distress (P=0.004), other symptoms (P=0.006), and difficulty in professional life (P=0.022). According to a study, patients with poor nutrition are more likely to develop PostCOVID-19 syndrome [63].

Sleeping disruption (66.7%) and chest distress (48.8 %) were frequent among those who had never had eggs or milk. Regular egg and milk consumers were significantly less likely to report Sleeping disturbance (P=0.039) and Chest distress (P=0.037). An overall healthy diet rich in fruits and vegetables, as well as bioactive compound constituents like omega-3 fatty acids, combined with a low intake of trans- fats and refined carbohydrates, has been found to improve psychological well-being and may thus play a role in recovery from the post-COVID-19 syndrome [64].

CONCLUSION
  • Survivors of COVID-19 experience fatigue, shortness of breath, and alopecia more often.
  • The occurrence of depression and short-term memory loss is significantly high, especially among women.
  • A substantial number of COVID-19 patients have faced harassment from their community.
  • Diet pattern influences persistent symptoms and mental health outcomes.
LIMITATIONS
  • Because telephone follow-up differs from face-to-face communication, the obtained data’s dependability may be compromised.
  • The study sample size was small.
  • Mental health outcomes were the sum score of diagnostic criteria and cut-off based; may lead to bias.
RECOMMENDATION
  • Proper care of persistent symptoms should take seriously.
  • Mental health should promote as a critical component of overall health.
  • Maintaining an adequate diet and regular physical exercise is necessary to fight against Covid-19.
  • Further studies on the individual topic need to conduct to know more about Covid-19 etiology.
REFERENCES
  1. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report–51. Geneva, Switzerland: World Health Organization; 2020.
  2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.
  3.  Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324: 603-605.
  4. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, BourbaoTournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021; 27: 258-263.
  5. Fjaeldstad AW. Prolonged complaints of chemosensory loss after COVID-19. Dan Med J. 2020; 67: A05200340.
  6. CDC (2020). https://www.cdc.gov/coronavirus/2019-ncov/ symptoms-testing/ symptoms.html
  7. Islam MS, Potenza MN, van Os J. Posttraumatic stress disorder during the COVID-19 pandemic: upcoming challenges in Bangladesh and preventive strategies. Int J Soc Psychiatry. 2021; 67: 205-206.
  8. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020; 11: 29.
  9. Duranton G, Puga D. The economics of urban density. JEP. 2020; 34: 3-26.
  10. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020; 368.
  11. Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. Int J Environ Health Res. 2018; 15: 1033.
  12. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004; 164: 2206-2216.
  13. Vickers NJ. Animal communication: when i’m calling you, will you answer too?. Curr Biol. 2017; 27: R713-R715.
  14. Zürcher K, Zwahlen M, Ballif M, Rieder HL, Egger M, Fenner L. Influenza pandemics and tuberculosis mortality in 1889 and 1918: analysis of historical data from Switzerland. PLoS One. 2016; 11: e0162575.
  15. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020; 52: 102066.
  16. Lee Y, Rosenblat JD, Lee J, Carmona NE, Subramaniapillai M, Shekotikhina M, et al. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. J Affect Disord. 2018; 227: 406-415.
  17. Gomez-Pinilla F. The influences of diet and exercise on mental health through hormesis. Ageing Res Rev. 2008; 7: 49-62.
  18. Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, eta al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020; 12: 1562.
  19. Al Saleh Y, Beshyah SA, Hussein W, Almadani A, Hassoun A, Al Mamari A, et al. Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: An expert consensus summary statement from the GCC vitamin D advisory board. Arch Osteoporos. 2020; 15: 35.
  20. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol. 2009; 158: 20-25.
  21. Leonard BE. The immune system, depression and the action of anti depressants. Prog Neuropsychopharmacol Biol Psychiatry. 2001; 25: 767-780.
  22. Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress. 2005; 18: 39-42.
  23. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020; 87: 18-22.
  24. Husain SF, Tang TB, Yu R, Tam WW, Tran B, Quek TT, et al. Cortical haemodynamic response measured by functional near infrared spectroscopy during a verbal fluency task in patients with major depression and borderline personality disorder. EBioMedicine. 2020; 51: 102586.
  25. Subramaniapillai M, Mansur RB, Zuckerman H, Park C, Lee Y, Iacobucci M, et al. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine. Compr Psychiatry. 2019; 94:152113.
  26. Al Zubayer A, Rahman ME, Islam MB, Babu SZD, Rahman QM, Bhuiyan MRAM, et al. Psychological states of Bangladeshi people four months after the COVID-19 pandemic: an online survey. Heliyon. 2020; 6: e05057.
  27. Islam MS, Sujan MSH, Tasnim R, Sikder MT, Potenza MN, Van Os J. Psychological responses during the COVID-19 outbreak among university students in Bangladesh. PloS one. 2020; 15: e0245083.
  28. Safa F, Anjum A, Hossain S, Trisa TI, Alam SF, Rafi MA, et al. Immediate psychological responses during the initial period of the COVID-19 pandemic among Bangladeshi medical students. Child Youth Serv Rev. 2021; 122: 105912.
  29. Tasnim R, Sujan M, Hossain S, Islam M, Ritu AH, Siddique M, et al. Prevalence and correlates of anxiety and depression in frontline healthcare workers treating people with COVID-19 in Bangladesh. BMC psychiatry. 2021; 21: 271.
  30. Mina FB, Billah M, Karmakar S, Das S, Rahman MS, Hasan MF, et al. An online observational study assessing clinical characteristics and impacts of the COVID-19 pandemic on mental health: a perspective study from Bangladesh. Z Gesundh Wiss. 2021; 1-9.
  31. Turner-Musa J, Ajayi O, Kemp L. Examining social determinants of health, stigma, and COVID-19 disparities. In Healthcare. 2020; 8: 168.
  32. Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020; 9: 29.
  33. Davison G, Kehaya C, Wyn Jones A. Nutritional and physical activity interventions to improve immunity. Am J Lifestyle Med. 2016; 10: 152-169.
  34. Lv X, Zhao S, Ning Z, Zeng H, Shu Y, Tao O, et al. Citrus fruits as a treasure trove of active natural metabolites that potentially provide benefits for human health. Chem Cent J. 2015; 9: 68.
  35. Suchitra MR, Parthasarathy S. International Journal Of Research in Pharmaceutical Sciences.2020.
  36. Konowalchuk J, Speirs JI. Antiviral effect of apple beverages. Appl Environ Microbiol. 1978; 36: 798-801.
  37. Aman F, Masood S. How Nutrition can help to fight against COVID-19 Pandemic. Pak J Med Sci. 2020; 36: 121-123.
  38. Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, et al. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 2020; 12: 1562.
  39. Lordan R, Tsoupras A, Zabetakis I. Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents. Blood Rev. 2021; 45: 100694.
  40. Matsuoka Y, Hamazaki K. Considering mental health from the viewpoint of diet: the role and possibilities of nutritional psychiatry. Seishin Shinkeigaku Zasshi. 2016; 118: 880-894.
  41. Paul R. “Bangladesh confirms its first three cases of coronavirus”. Reuters. 2020.
  42. (IEDCR), Institute of Epidemiology, Disease Control and Research. Y TNT \NYNT. corona.gov.bd (in Bengali). Archived from the original on 22 March 2020. Retrieved 3 May 2020.
  43. Nooruddin I, Shahid R. Defusing Bangladesh’s COVID-19 time bomb. Atlantic Council. 2020; 30.
  44. 10 ICU beds for 1.2 million: COVID-19 catastrophe looms in Cox’s Bazar. Reliefweb, 2020.
  45. Y TNT T\ T : ? T ¢ TYR RT?YR ?R?Y. Prothom Alo (in Bengali). Archived from the original on 30 March 2020. Retrieved 30 March 2020.
  46. Chowdhury AN, Ghosh S, Sanyal D. Bengali adaptation of brief patient health questionnaire for screening depression at primary care. J Indian Med Assoc. 2004; 102: 544-547.
  47. Moonajilin MS, Rahman ME, Islam MS. Relationship between overweight/obesity and mental health disorders among Bangladeshi adolescents: a cross-sectional survey. Obes Med. 2020; 18:100216.
  48. Islam S, Akter R, Sikder T, Griffiths MD. Prevalence and factors associated with depression and anxiety among first-year university students in Bangladesh: a cross-sectional study. Int J Ment Health Addict. 2020; 1-14.
  49. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care Evaluation of Mental Disorders. Patient Health Questionnaire. Jama. 1999; 282: 1737-1744.
  50. Liu D, Baumeister RF, Veilleux JC, Chen C, Liu W, Yue Y, et al. Risk factors associated with mental illness in hospital discharged patients infected with COVID-19 in Wuhan, China. Psychiatry Res. 2020; 292: 113297.
  51. Islam M, Ferdous M, Islam US, Mosaddek ASM, Potenza MN, Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021; 18: 1453.
  52. Tran BX, Nguyen HT, Le HT, Latkin CA, Pham HQ, Vu LG, et al. Impact of COVID-19 on economic well-being and quality of life of the Vietnamese during the national social distancing. Front Psychol. 2020; 11: 565153.
  53. Keelery S. Impact on household income due to the coronavirus (COVID-19) in India from February to April 2020. 2020.
  54. Iqbal F M, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. 2021; 36: 100899.
  55. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it?. Lung. 2021; 199: 113- 119.
  56. Barrea L, Pugliese G, Framondi L, Di Matteo R, Laudisio D, Savastano S, et al. Does Sars-Cov-2 threaten our dreams? Effect of quarantine on sleep quality and body mass index. J Transl Med. 2020; 18: 318.
  57. Krishnamoorthy Y, Nagarajan R, Saya GK, Menon V. Prevalence of psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic: A systematic review and meta-analysis. Psychiatry Research. 2020; 293, 113382.
  58. Hossain S, Anjum A, Uddin ME, Rahman MA, Hossain MF. Impacts of socio- cultural environment and lifestyle factors on the psychological health of university students in Bangladesh: a longitudinal study. J Affect Disord. 2019; 256: 393-403.
  59. Van Droogenbroeck F, Spruyt B, Keppens G. Gender differences in mental health problems among adolescents and the role of social support: results from the Belgian health interview surveys 2008 and 2013. BMC Psychiatry. 2018; 18: 6.
  60. Matheson FI, Smith KL, Moineddin R, Dunn JR, Glazier RH. Mental health status and gender as risk factors for onset of physical illness over 10 years. J Epidemiol Community Health. 2014; 68: 64-70.
  61. Klok FA, Boon GJ, Barco S, Endres M, Geelhoed JM, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020; 56: 2001494
  62. Lassale C, Batty GD, Baghdadli A, Jacka F, Sánchez-Villegas A, Kivimäki M, et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019; 24: 965-986.
  63. Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020; 87: 53-54.
  64. Barrea L, Grant WB, Frias-Toral E, Vetrani C, Verde L, de Alteriis G, et al. Dietary recommendations for post-COVID-19 syndrome. Nutrients. 2022; 14: 1305.
Received : 03 Apr 2023
Accepted : 28 Mar 2023
Published : 29 Mar 2023
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X